To Compare the Safety and Efficacy of "HG-102" With Botox® in the Improvement of Moderate to Severe Glabellar Lines.

NCT04944953 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Glabellar Lines

Interventions

DRUG: Botulinum Toxin Type A Injection [Botox]
DRUG: Botulinum toxin type A injection [HG-102]

Sponsor

Hugel